loader image
Wednesday, November 19, 2025
89.6 F
McAllen
- Advertisement -

VIDA receives a $25k Blue Impact℠ Grant from Blue Cross and Blue Shield of Texas

Translate to Spanish or other 102 languages!

Valley Initiative for Development and Advancement (VIDA)announced it received a Blue ImpactSM grant from Blue Cross and Blue Shield of Texas (BCBSTX), an award reflecting BCBSTX's dedication to community-based organizations that prioritize the well-being of children and families. Courtesy image
Valley Initiative for Development and Advancement (VIDA)announced it received a Blue ImpactSM grant from Blue Cross and Blue Shield of Texas (BCBSTX), an award reflecting BCBSTX’s dedication to community-based organizations that prioritize the well-being of children and families. Courtesy image

Mega Doctor News

- Advertisement -

Valley Initiative for Development and Advancement (VIDA)announced it received a Blue ImpactSM grant from Blue Cross and Blue Shield of Texas (BCBSTX), an award reflecting BCBSTX’s dedication to community-based organizations that prioritize the well-being of children and families.

The grant recognizes the crucial role of local organizations in fostering positive change, tackling underlying factors that influence health, including socio-economic challenges, and promoting economic opportunities. Since its launch in early 2023, BCBSTX has allocated $2.93 million to community-based organizations, underscoring the company’s commitment to promoting comprehensive wellness across the state. 

“These grants facilitate healthier futures for children and families in Texas,” said Sheena Payne, BCBSTX’s director of Community Investments. “We’re committed to sustainable solutions with community partners to make a meaningful difference in the lives of those who need it most and to lay the groundwork for economic empowerment.” The newly re-named Blue Impact program has awarded nearly $23 million since its inception, and this year is expected to impact nearly 4 million children and adults in Texas. 

- Advertisement -

“We are immensely grateful to Blue Cross and Blue Shield of Texas, for selecting VIDA as a recipient of this $25,000 grant. It is our continued priority to support our Latino and low-income residents achieve economic mobility through relevant and high wage career pathways. This grant will allow VIDA to continue providing the essential wraparound support services for successful program completion and professional advancement. Thank you BCBSTX for recognizing the importance of investing in human capital to promote workforce development and economic prosperity of our region, said Felida Villarreal, VIDA’s President & CEO.

To learn more about VIDA, please visit www.vidacareers.org or call (956) 903-1900.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS’ South Texas Healthy Living Episode on Diabetes Awareness, Nov. 30th

The United States is experiencing a national health crisis as the incidence of diabetes continues to climb across the country.

Colorectal Cancer Screenings Remain Low For People Ages 45 To 49

UCLA research finds that fewer than 1 in 4 eligible younger adults completed colorectal cancer screenings after the United States Preventive Services Task Force (USPSTF) lowered the recommended screening age to 45 from 50.

DHR Health Encourages Early Detection with $99 Lung Cancer Screening Special Thru Dec. 31st

Lung cancer remains the leading cause of cancer death in the United States, accounting for about one in five cancer deaths nationwide. According to the American Cancer Society, an estimated 226,650 new cases of lung cancer will be diagnosed in 2025, and 124,730 people are expected to die from the disease. Each year, lung cancer claims more lives than colon, breast, and prostate cancers combined.

Aesculap Implant Systems Settles for $38.5M, Enters Non-Prosecution Deal

Medical device company Aesculap Implant Systems LLC (Aesculap), based in Center Valley, Pennsylvania, has agreed to pay $38.5 million to resolve allegations under the False Claims Act that the company sold knee replacement devices that it knew would fail prematurely at a higher than acceptable rate, resulting in false claims to Medicare and Medicaid.
- Advertisement -
×